ArticleUrology practice2024

The 340B Program and High-Risk Prescribing of Oral Targeted Therapies for Advanced Prostate Cancer.

Kassem S Faraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.